Stopping GLP-1s Increases Risk of Cardiovascular Disease - European Medical Journal

Stopping GLP-1s Increases Risk of Cardiovascular Disease  European Medical JournalHeart benefits fade after stopping GLP-1 medications  The Atlanta VoiceStopping Ozempic and Similar Drugs Puts Your Heart at Risk Again  eu-policies.comWeight-loss drug Mounjaro reverses health benefits when you stop taking it, study finds  MSNStopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds  930 WFMD Free Talk